Urine Markers Do Not Predict Biopsy Findings or Presence of Bladder Ulcers in Interstitial Cystitis/Painful Bladder Syndrome
- 1 May 2008
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 179 (5) , 1850-1856
Abstract
We tested for associations between urine markers, bladder biopsy features and bladder ulcers in interstitial cystitis/painful bladder syndrome. Subjects were 72 patients with interstitial cystitis/painful bladder syndrome undergoing bladder distention and biopsy. Urine was collected before the procedure. Urine marker levels were correlated with biopsy and cystoscopic findings. Patients with no previous interstitial cystitis/painful bladder syndrome treatments (47) were analyzed separately from previously treated patients (25). For untreated patients urine interleukin-6 and cyclic guanosine monophosphate were associated with urothelial epidermal growth factor receptor staining (for interleukin-6 r = 0.29; 95% CI 0.07, 0.51; p = 0.01 and for cyclic guanosine monophosphate r = 0.34; 95% CI 0.13, 0.55; p = 0.002). Urine interleukin-8 was negatively associated with urothelial heparin-binding epidermal growth factor-like growth factor staining (r = -0.34; 95% CI -0.55, -0.12; p = 0.002) and positively associated with lamina propria mast cell count (r = 0.29; 95% CI 0.06, 0.52; p = 0.01). The latter association also was seen in treated patients (r = 0.46; 95% CI 0.20, 0.73; p <0.001). None of the urine markers was significantly different for ulcer vs nonulcer groups. All of the patients with ulcer had extensive inflammation on bladder biopsy including severe mononuclear cell infiltration, moderate or strong interleukin-6 staining in the urothelium and lamina propria, and leukocyte common antigen staining in more than 10% of the lamina propria. However, these features also were seen in 24% to 76% of the patients without ulcer. Overall urine markers did not associate robustly with biopsy findings. The strongest association was a positive association between urine interleukin-8 levels and bladder mast cell count. Patients with ulcer consistently had bladder inflammation but the cystoscopic finding of ulcers was not a sensitive indicator of inflammation on bladder biopsy.Keywords
This publication has 25 references indexed in Scilit:
- Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretionJournal of Clinical Investigation, 2006
- EFFICACY OF PREDNISONE FOR SEVERE REFRACTORY ULCERATIVE INTERSTITIAL CYSTITISJournal of Urology, 2005
- DO THE NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES CYSTOSCOPIC CRITERIA ASSOCIATE WITH OTHER CLINICAL AND OBJECTIVE FEATURES OF INTERSTITIAL CYSTITIS?Journal of Urology, 2005
- ABNORMAL EXPRESSION OF MOLECULAR MARKERS FOR BLADDER IMPERMEABILITY AND DIFFERENTIATION IN THE UROTHELIUM OF PATIENTS WITH INTERSTITIAL CYSTITISJournal of Urology, 2004
- Mast Cell Activation Triggers a Urothelial Inflammatory Response Mediated by Tumor Necrosis Factor-αJournal of Urology, 2002
- Toward a Precise Definition of Interstitial Cystitis: Further Evidence of Differences in Classic and Nonulcer DiseaseJournal of Urology, 2002
- A Comparison of Multiple Urine Markers for Interstitial CystitisJournal of Urology, 2002
- USE OF THE NEODYMIUM: YAG LASER FOR INTERSTITIAL CYSTITIS: A PROSPECTIVE STUDYJournal of Urology, 2001
- BLADDER EPITHELIAL CELLS FROM PATIENTS WITH INTERSTITIAL CYSTITIS PRODUCE AN INHIBITOR OF HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR PRODUCTIONJournal of Urology, 2000
- ORIGIN OF URINARY EPIDERMAL GROWTH FACTOR IN HUMANS: EXCRETION OF ENDOGENOUS EGF AND INFUSED [131I]‐HUMAN EGF AND KIDNEY HISTOCHEMISTRYClinical and Experimental Pharmacology and Physiology, 1992